Medical Condition News

RSS

Rich Pharmaceuticals obtains FDA approval to begin Phase 1/2 study in AML and MDS patients

Rich Pharmaceuticals, Inc. is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients.

28 Dec 2015

Genetic modification in esophagus can lead to esophageal cancer

A genetic modification in the mucous membrane of the esophagus, the Barrett esophagus, can lead to esophageal cancer. If certain biomarkers are contained in these tissue alterations, so-called miDNA, these are extremely short DNA strands, it could be an indication that this preliminary stage of esophageal cancer indeed leads to cancer.

28 Dec 2015

Julphar's DEXCOM G4 PLATINUM CGM system now available in GCC

The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and Lebanon. With this unique technology, diabetic patients can easily and conveniently monitor their glucose level around the clock.

28 Dec 2015

New study looks at overconsumption of 'healthy' foods

Eating too much is typically considered one of the prime culprits of obesity. A new study published in the Journal of the Association for Consumer Research, looked specifically at overconsumption of "healthy" foods which consumers often perceive as less filling.

28 Dec 2015

Researchers identify new gene that helps maintain chromosome number in cells

Molecular biologists at UT Southwestern Medical Center have identified a gene called NORAD that helps maintain the proper number of chromosomes in cells, and that when inactivated, causes the number of chromosomes in a cell to become unstable, a key feature of cancer cells.

26 Dec 2015

Microencapsulation method can help overcome challenges in pancreatic islet transplantation

A microencapsulation method, developed by OIST researchers, can help to overcome major challenges in pancreatic islet transplantation.

26 Dec 2015

3D maps of spatial organization may help find genes involved in hereditary diseases

It has now been 15 years since scientists celebrated the completion of the human genome. At that point, scientists had determined the entire sequence of the genetic letters making up our DNA.

26 Dec 2015

Concussion expert shares important information on sports-related concussions

The Sports Concussion Program in the Children's Orthopaedic Center at Children's Hospital Los Angeles is the only pediatric program of its kind in Southern California.

26 Dec 2015

Researchers identify liver-derived hormone that regulates sugar intake

We all love our sugar, especially during the holidays. Cookies, cake, and candy are simply irresistible. While sugar cravings are common, the physiological mechanisms that trigger our "sweet tooth" are not well defined.

24 Dec 2015

TweetChat on AAN's guideline for diagnosing and treating sports concussions

As the nation expands its conversation about sports concussion this week, the American Academy of Neurology, the world's most trusted authority on concussion, will host a TweetChat at 1 p.m. ET, Monday, December 28, to help educate parents, coaches and athletes about the AAN's guideline for diagnosing and treating sports concussion.

24 Dec 2015

Healthier weight using genetic data for customized diets and physical activity plans

Some health experts predict that the next big advance in helping overweight people achieve a healthier weight will be to use an individual's genetic data to customize diets and physical activity plans, an approach known as "precision weight loss.

24 Dec 2015

Lower vitamin D levels do not increase severity of obstructive sleep apnea

A recent study of elderly men found no evidence that obstructive sleep apnea (OSA) increased in severity (or prevalence) as a result of vitamin D deficiency.

24 Dec 2015

Collaborative team to determine mechanisms that cause traumatic brain injuries due to shockwaves

Nearly 300,000 soldiers have returned from service in Iraq and Afghanistan with symptoms of traumatic brain injuries due to blast shockwaves. Such injuries often go untreated because they are undetected by brain scans despite the symptoms' presence.

24 Dec 2015

Ultrafast near-infrared lasers deliver gene therapy to treat macular degeneration

Millions of adults over age 50 struggle each year with vision loss caused by damage to the retina or common macular degeneration.

24 Dec 2015

Personalized respiratory-motion system enables more precise lung cancer imaging

Lung cancer patients know that precise medical imaging can help a surgeon eradicate tumors and preserve healthy tissue.

24 Dec 2015

Pacemaker Induced Transient Asynchrony could help slow down progression of heart failure

Johns Hopkins has demonstrated in animals that applying a pacemaker's mild electrical shocks to push the heart in and out of normal synchronized contraction for part of each day may be an effective way to slow down the progression of heart failure, a disorder that afflicts millions of Americans.

24 Dec 2015

Study directly links common variants of Alzheimer's risk genes to atrophy

Two genetic variants previously linked to Alzheimer's disease have been more specifically tied to brain atrophy that is characteristic of the disease.

24 Dec 2015

Positive interim results from TWIB's AC-201 CR Phase 2 study for hyperuricemia and gout

TWi Biotechnology Inc. today announced interim results from the ongoing Phase 2 proof of concept clinical study evaluating AC-201 CR as an oral uricosuric and anti-inflammatory agent for the treatment of hyperuricemia and prevention of gout flares combining with febuxostat, a xanthine oxidase inhibitor.

24 Dec 2015

Novel antibody improves glucose regulation and reduces fatty liver in obese mice

A new study by researchers from Harvard T.H. Chan School of Public Health and colleagues describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other metabolic diseases.

24 Dec 2015

Sanofi seeks FDA NDA approval for once-daily fixed-ratio combination of insulin glargine and lixisenatide

Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.

24 Dec 2015

Medical Condition News

Rich Pharmaceuticals obtains FDA approval to begin Phase 1/2 study in AML and MDS patients

Genetic modification in esophagus can lead to esophageal cancer

Julphar's DEXCOM G4 PLATINUM CGM system now available in GCC

New study looks at overconsumption of 'healthy' foods

Researchers identify new gene that helps maintain chromosome number in cells

Microencapsulation method can help overcome challenges in pancreatic islet transplantation

3D maps of spatial organization may help find genes involved in hereditary diseases

Concussion expert shares important information on sports-related concussions

Researchers identify liver-derived hormone that regulates sugar intake

TweetChat on AAN's guideline for diagnosing and treating sports concussions

Healthier weight using genetic data for customized diets and physical activity plans

Lower vitamin D levels do not increase severity of obstructive sleep apnea

Collaborative team to determine mechanisms that cause traumatic brain injuries due to shockwaves

Ultrafast near-infrared lasers deliver gene therapy to treat macular degeneration

Personalized respiratory-motion system enables more precise lung cancer imaging

Pacemaker Induced Transient Asynchrony could help slow down progression of heart failure

Study directly links common variants of Alzheimer's risk genes to atrophy

Positive interim results from TWIB's AC-201 CR Phase 2 study for hyperuricemia and gout

Novel antibody improves glucose regulation and reduces fatty liver in obese mice

Sanofi seeks FDA NDA approval for once-daily fixed-ratio combination of insulin glargine and lixisenatide

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News